Sub-Q Bionics

Company Overview

Snapshot

Founded in February 2025, Sub-Q Bionics operates with 1–10 employees. The company has raised $1.5M across one funding round, demonstrating early investor confidence in its innovative medical device technology.

Business overview

Sub-Q Bionics is a Health Tech & Life Sciences company developing an implantable device for lymphedema patients. Its core technology provides continuous fluid management, offering an alternative to daily compression therapy. The company operates within the Medical Devices and Medical Treatment & Therapeutics sectors, targeting the healthcare industry with a B2B business model.

Company Intelligence Q&A

What is Sub-Q Bionics' primary focus?

Sub-Q Bionics is developing an implantable device designed to provide continuous fluid management for lymphedema patients, aiming to replace the need for daily compression therapy.

When was Sub-Q Bionics founded?

Sub-Q Bionics was founded in February 2025.

What is the current employee size of Sub-Q Bionics?

Sub-Q Bionics currently has 1–10 employees.

What is Sub-Q Bionics' current product development stage?

Sub-Q Bionics' product is currently in the R&D stage, focusing on developing an implantable device for lymphedema patients.

What is the total capital raised by Sub-Q Bionics?

Sub-Q Bionics has raised a total of $1.5M in funding.